Stock-Based Compensation Expense (Tables)

3 Months Ended

Mar. 31, 2026

A summary of stock option award activity for the three months ended March 31, 2026 was as follows:


Options	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term
Outstanding at December 31, 2025	484,770	$	9.30	6.5
Granted	—	—
Exercised	—	—
Cancelled or forfeited	—	—
Outstanding at March 31, 2026	484,770	$	9.30	6.3
Exercisable at March 31, 2026	263,348	$	13.97	4.8

A summary of stock option award activity for the three months ended March 31, 2025 was as follows:


Options	Shares	Weighted Average Exercise Price		Weighted Average Remaining Contractual Term
Outstanding at December 31, 2024	488,385	$	9.34	7.5
Granted	—	$	—
Exercised	—	—
Cancelled or forfeited	—	—
Outstanding at March 31, 2025	488,385	$	9.34	7.3
Exercisable at March 31, 2025	192,985	$	17.86	4.5

Restricted stock units activity during the three months ended March 31, 2026 was as follows:


	Number of Shares	Weighted Average Grant Date Fair Value Per Share
Non-vested, at December 31, 2025	3,674,502	$	2.39
Granted	187,500	2.00
Vested	—	—
Cancelled or forfeited	(85,782)	2.22
Non-vested, at March 31, 2026	3,776,220	$	2.37

Restricted stock units activity during the three months ended March 31, 2025 was as follows:


	Number of Shares	Weighted Average Grant Date Fair Value Per Share
Non-vested, at December 31, 2024	2,233,816	$	4.60
Granted	—	—
Vested	(28,732)	5.92
Cancelled or forfeited	(153,945)	3.13
Non-vested, at March 31, 2025	2,051,139	$	4.69